Mahipals Sachdev News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India News: ChrysCapital invests $100 million in New Delhi's Centre For Sight (CFS), acquiring 30.8% stake from Mahindra Holdings. Founded by Dr Mahipal S Sachdev

Over-the-counter eye drops, easily accessible in the market, pose a risk of ailments among kids if used without monitoring, say doctors. Increased use of these eye drops because of itching or infection from pollution and excessive screen time can lead to serious ailments. In worst cases, they can also lead to glaucoma.

ChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in the chain. At present, Centre For Sight founder Dr Mahipal S Sachdev is the majority stakeholder with about 55% stake in the chain. Another 10% stake has been given under employee stock ownership plan.

Ranchi: Director General of Police (DGP) Ajay Kumar Singh on Wednesday asked the field officers to complete investigation of the pending cases related.

A new technology called SILK has been unveiled in New Delhi, India, which allows people with myopia to achieve clear vision without glasses or lenses. The procedure, which involves the creation and removal of a tiny lens within the cornea, was launched at the annual conference of the Intraocular Implant & Refractive Society of India. The advancement in vision-improvement technology is expected to have a positive impact on the economic growth of the country, according to Lok Sabha Speaker Om Birla. The prevalence of myopia in India is expected to increase to 31.89% by 2030. | Latest News India